Leishmaniasis vaccines: Past, present and future

International Journal of Antimicrobial Agents

Volumn 36, Issue SUPPL. 1, 2010, Pages

  Modabber, Farrokh ^a  

^a Drugs for Neglected Diseases Initiative DNDi   (Switzerland)

Author keywords

Emerging infectious disease; Immunochemotherapy; Immunotherapy; Leishmaniasis; Prophylaxis; Vaccine

Indexed keywords

LEISHMANIA VACCINE;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOGENICITY; IMMUNOTHERAPY; LEISHMANIASIS; NONHUMAN; POLITICS; PRIORITY JOURNAL; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

ANIMALS; DRUG DISCOVERY; HUMANS; LEISHMANIASIS; LEISHMANIASIS VACCINES; ZOONOSES;

EID: 77957937010     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.06.024     Document Type: Article

References (15)

1. Modabber F., Coler R., Reed S. Vaccines against Leishmania. New generation vaccines 2010, 790-807. Informa Healthcare, New York, London. 4th ed. M.M. Levine, M. Dougan, G. Nabel, M.F. Good, J. Nataro, M.A. Liu (Eds.).
2. Antunes C.M., Mayrink W., Magalhaes P.A., Costa C.A., Melo M.N., Dias M., et al. Controlled field trials of a vaccine against New World cutaneous leishmaniasis. Int J Epidemiol 1986, 15:572-580.
3. Velez I.D., Gilchrist K., Arbelaez M.P., Rojas C.A., Puerta J.A., Antunes C.M.F., et al. Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia. Trans R Soc Trop Med Hyg 2005, 99:593-598.
4. Armijos R.X., Weigel M.M., Aviles H., Maldonado R., Racines J. Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up. J Infect Dis 1998, 177:1352-1357.
5. Momeni A.Z., Jalayer T., Emamjomeh M., Khamesipour A., Zicker F., Ghassemi R.L., et al. A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran. Vaccine 1999, 17:466-472.
6. Sharifi I., FeKri A.R., Aflatonian M.R., Khamesipour A., Nadim A., Mousavi M.R., et al. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet 1998, 351:1540-1543.
7. Khalil E.A., El Hassan A.M., Zijlstra E.E., Mukhtar M.M., Ghalib H.W., Musa B., et al. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet 2000, 356:1565-1569.
8. Noazin S., Modabber F., Khamesipour A., Smith P.G., Moultone L.H., Nasseri Q., et al. First generation leishmaniasis vaccines: a review of field efficacy trials. Vaccine 2008, 26:6759-6767.
9. Machado-Pinto J., Pinto J., da Costa C.A., Genaro O., Marques M.J., Modabber F., et al. Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial. Int J Dermatol 2002, 41:73-78.
10. Musa A.M., Khalil E.A., Mahgoub F.A., Elgawi S.H., Modabber F., Elkadaru A.E. Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. Trans R Soc Trop Med Hyg 2008, 102:58-63.
11. Coler R.N., Goto Y., Bogatzki L., Raman V., Reed S.G. Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells. Infect Immun 2007, 75:4648-4654.
12. Vélez I.D., Gilchrist K., Martínez S., Ramírez-Pineda J.R., Ashman J.A., Alves F.P., et al. Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis. Vaccine 2009, 28:329-337.
13. Rapsodi against leishmaniasis. [accessed 12 May 2010]. http://www.fp7-rapsodi.eu/.
14. Development of a DNA vaccine for visceral leishmaniasis: LEISHDNAVAX. European Commission Research-Health, [accessed 10 May 2010]. http://ec.europa.eu/research/health/infectious-diseases/neglected-diseases/projects/006_en.html.
15. Khamesipour A., Dowlati Y., Asilian A., Hashemi-Fesharki R., Javadi A., Noazin S., et al. Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine 2005, 23:3642-3648.